Page last updated: 2024-10-28

hexamethylene bisacetamide and Carotid Stenosis

hexamethylene bisacetamide has been researched along with Carotid Stenosis in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishikawa, S1
Hori, S1
Kusuhara, M1
Kanai, Y1
Handa, S1
Yamaguchi, K1
Hosoda, Y1
Ogawa, S1

Other Studies

1 other study available for hexamethylene bisacetamide and Carotid Stenosis

ArticleYear
Differentiating agent, hexamethylene bisacetamide, inhibits neointimal formation after vascular injury.
    Coronary artery disease, 1997, Volume: 8, Issue:1

    Topics: Acetamides; Animals; Carotid Artery Injuries; Carotid Stenosis; Catheterization; Cell Count; Cell Di

1997